PanLeucogated CD4 Test HIV SA: Wits Study $626M Saved | AcademicJobs
A Wits University study shows the PanLeucogated CD4 test saved $626M over 20 years, enabling massive HIV monitoring scale-up in South Africa.
No reviews yet. Be the first to rate Lindi-Marie!
Doctor Lindi-Marie Coetzee is a Senior Researcher at the Wits Diagnostic Innovation Hub in the Faculty of Health Sciences at the University of the Witwatersrand. She holds a BSc, BScHons, MSc and PhD from the University of the Free State. Coetzee is also affiliated with the National Health Laboratory Service and the National Priority Programme in Johannesburg. Her professional contributions centre on diagnostic innovation and laboratory services, with involvement in research on HIV-related testing, CD4 count trends and cryptococcal antigen diagnostics in South Africa.
She has co-authored publications addressing the economic impact of diagnostic strategies, the implementation of tiered CD4 service models and specimen loss assessments in laboratory settings. Coetzee maintains an active role in advancing laboratory medicine through her position at the Wits Diagnostic Innovation Hub.
A Wits University study shows the PanLeucogated CD4 test saved $626M over 20 years, enabling massive HIV monitoring scale-up in South Africa.